The ethics of clinical trials

ecancermedicalscience

Volumn 8, Issue 1, 2014, Pages

  Nardini, Cecilia ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Ethics; Personalized medicine; Precision medicine; RCTs; Research

Indexed keywords

EID: 84894542159     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2014.387     Document Type: Article

References (39)

1. Jones JH (1993 [1981]) Bad Blood: The Tuskegee Syphilis Experiment, expanded edn (New York: The Free Press).
2. (1949) The Nuremberg Code. Trials of war criminals before the Nuremberg military tribunals under control council law Transcripts available at http://nuremberg.law.harvard.edu/php/docs-swi.php?%20DI=1&text=medical. Last accessed 14/10/13.
3. World Medical Association (2008) Declaration of Helsinki, 6th revision Available at http://www.wma.net/en/30publications/10policies/b3/. Last accessed 14/10/13.
4. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Bethesda, MD (1978) The Belmont report: Ethical principles and guidelines for the protection of human subjects of research (ERIC Clearinghouse).
5. Howick JH (2011) The Philosophy of Evidence-Based Medicine (London: Wiley-Blackwell). DOI: 10.1002/9781444342673
6. Teira D and Reiss J (2013) Causality, Impartiality and Evidence-Based Policy ed Chao H-K, Cheng S-T and Millstein RL Mechanism and Causality in Biology and Economics pp 207-24 (the Netherlands: Springer). DOI: 10.1007/978-94-007-2454-9-11
7. Goodman SN (1999) Toward evidence-based medical statistics. 1: the P value fallacy Ann Intern Med 130 995. DOI: 10.7326/0003-4819-130-12-199906150- 00008 PMID: 10383371
8. Sackett DL et al (2004) Evidence-Based Medicine: How to Practice and Teach EBM 2nd edn (New York: Churchill Livingstone).
9. Berg JW et al (2001) Informed Consent: Legal Theory and Clinical Practice 2nd edn (New York: Oxford University Press).
10. Herz DA, Looman JE and Lewis SK (1992) Informed consent: is it a myth? Neurosurgery 30(3) 453-8. DOI: 10.1227/00006123-199203000-00028 PMID: 1620316
11. Appelbaum PS and Lidz CW (2008) The Therapeutic Misconception ed Emanuel EJ et al The Oxford Textbook of Clinical Research Ethics pp 633-43 (Oxford: Oxford University Press).
12. Miller F and Brody H (2003) A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials Hastings Cent Rep 33 19-28. DOI: 10.2307/3528434 PMID: 12854452
13. Wendler D and Miller F (2004) Deception in the pursuit of science Arch Intern Med 164 597-600. DOI: 10.1001/archinte.164.6.597 PMID: 15037487
14. Deng C et al (2012) Challenges of clinical trial design when there is lack of clinical equipoise: use of a response conditional crossover design J Neurol 259 348-52. DOI: 10.1007/s00415-011-6200-0 PMCID: 3268968
15. Temple R and Ellenberg SS (2000) Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues Ann Intern Med 133(6) 455-63. DOI: 10.7326/0003-4819-133-6- 200009190-00014 PMID: 10975964
16. Anderson JA (2006) The ethics and science of placebo-controlled trials: assay sensitivity and the Duhem-Quine thesis J Med Philos 31 65-81. DOI: 10.1080/03605310500499203 PMID: 16464770
17. Howick J (2009) Questioning the methodologic superiority of 'placebo' over 'active' controlled trials AJoB 9 34-48.
18. Hellman S and Hellman DS (1991) Of mice but not men: problems of the randomized clinical trial N Engl J Med 324(22) 1585-9. DOI: 10.1056/ NEJM199105303242208 PMID: 2027362
19. Freedman B (1987) Equipoise and the ethics of clinical research N Engl J Med 317 141-5. DOI: 10.1056/NEJM198707163170304 PMID: 3600702
20. Edwards SJ et al (1998) Ethical issues in the design and conduct of randomised controlled trials Health Technol Assess 2(15) 1-132.
21. Sackett D (2000) Why randomized controlled trials fail but needn't: 1. failure to gain "coal-face"commitment and to use the uncertainty principle CMAJ 162 1311-14. PMID: 10813014 PMCID: 1232415
22. Lilford RJ (2003) Ethics of clinical trials from a Bayesian and decision-analitic perspective: whose equipoise is it anyway? BMJ 326 980-81. DOI: 10.1136/bmj.326.7396.980 PMID: 12727776 PMCID: 1125887
23. Palmer CR and Rosenberger WF (1999) Ethics and practice: alternative designs for phase III randomized clinical trials Control Clin Trials 20(2) 172-86. DOI: 10.1016/S0197-2456(98)00056-7 PMID: 10227416
24. Glantz LH et al (1998) Research in developing countries: taking "benefit"seriously Hastings Cent Rep 28 38-42. DOI: 10.2307/3528268 PMID: 9868610
25. Shapiro H and E Meslin (2001) Ethical issues in the design and conduct of clinical trials in developing countries N Engl J Med 345 139-42. DOI: 10.1056/NEJM200107123450212 PMID: 11450665
26. Riis P (2003) Thirty years of bioethics: the Helsinki Declaration 1964-2003 New Rev Bioeth 1 15-25. DOI: 10.1080/1740028032000131396
27. Miller FG and Wertheimer A (2007) Facing up to paternalism in research ethics Hastings Cent Rep 37(3) 24-34. DOI: 10.1353/hcr.2007.0044 PMID: 17649900
28. Kummar S et al (2007) Compressing drug development timelines in oncology using phase '0' trials Nat Rev Cancer 7(2) 131-9. DOI: 10.1038/nrc2066 PMID: 17251919
29. Giordano S (2010) The 2008 Declaration of Helsinki: some reflections J Med Ethics 36 598-603. DOI: 10.1136/jme.2009.034132 PMID: 20813718
30. McCulloch P et al (2002) Randomised trials in surgery: problems and possible solutions BMJ 324 1448-51. DOI: 10.1136/bmj.324.7351.1448 PMID: 12065273 PMCID: 1123389
31. Lee C and Morton CC (2008) Structural genomic variation and personalized medicine N Engl J Med 358(7) 740-41. DOI: 10.1056/NEJMcibr0708452 PMID: 18272898
32. Longo Dan L (2012) Tumor heterogeneity and personalized medicine N Engl J Med 366(10) 956-7. DOI: 10.1056/NEJMe1200656 PMID: 22397658
33. Fleck LM (2010) Personalized medicine's ragged edge Hastings Cent Rep 40(5) 16-18. DOI: 10.1353/hcr.2010.0005 PMID: 20964159
34. Wistuba II et al (2012) Methodological and practical challenges for personalized cancer therapies Nat Rev Clin Oncol 8 135-41. DOI: 10.1038/nrclinonc.2011.2
35. Sharma MR and Schilsky RL (2012) Role of randomized phase III trials in an era of effective targeted therapies Nat Rev Clin Oncol 9(4) 208-14. DOI: 10.1038/nrclinonc.2011.190
36. Halpern SD, Karlawish JHT and Berlin JA (2002) The continuing unethical conduct of underpowered clinical trials JAMA 288 358-62. DOI: 10.1001/jama.288.3.358 PMID: 12117401
37. Ioannidis JPA and Khoury MJ (2013) Are randomized trials obsolete or more important than ever in the genomic era? Genome Med 5 32. DOI: 10.1186/gm436 PMID: 23673134 PMCID: 3707036
38. Worrall J (2008) Evidence and ethics in medicine Perspect Biol Med 51(3) 418-31. DOI: 10.1353/pbm.0.0040 PMID: 18723945
39. Nardini C, Annoni M and Schiavone G (2012) Mechanistic understanding in clinical practice: complementing evidence-based medicine with personalized medicine J Eval Clin Pract 18(5) 1000-5. PMID: 22994998